MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

21.55 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,197
Open 21.55
Bid (Size) 21.21 (100)
Ask (Size) 21.79 (700)
Prev. Close 21.55
Today's Range 21.55 - 21.55
52wk Range 9.130 - 22.43
Shares Outstanding 148,077,055
Dividend Yield 1.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Chemours Company (NYSE: CC): A Deep Dive into a Chemical Giant at a Crossroads
Date: March 25, 2026 Introduction The Chemours Company (NYSE: CC) is currently standing at one of the most pivotal crossroads in its decade-long history as an independent entity. As a global leader in... 
Via Finterra
Topics Earnings Economy Emissions
News headline image
Titanium and Transformation: A Deep Dive into Tronox Holdings plc (TROX)
As of March 25, 2026, the global chemical and mining industries are at a critical crossroads, and few companies embody this tension more than Tronox Holdings plc (NYSE: TROX). As a premier vertically... 
Via Finterra
Topics Bankruptcy Economy Electric Vehicles

Performance

YTD
+75.9%
+75.9%
1 Month
+31.3%
+31.3%
3 Month
+69.2%
+69.2%
6 Month
+36.4%
+36.4%
1 Year
+104.7%
+104.7%

More News

Read More
Chemours (NYSE:CC) Stock Plummets 11% After Q4 Earnings Miss Estimates ↗
Via Chartmill
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
From Pomerantz LLP
Via GlobeNewswire
News headline image
Gabelli Hosts 17th Annual Specialty Chemicals Symposium
From Gabelli Funds
Via GlobeNewswire
News headline image
Why Chemours Plunged Today ↗
Via The Motley Fool
News headline image
Supply-Side Discipline: Tronox Defies Tepid Demand to Push Titanium Dioxide Pricing Higher
Via MarketMinute
Topics Bankruptcy Economy
News headline image
Chemours (CC) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Hexcel Now 23% of This Portfolio After $7.5 Million Buy and 32% Stock Surge ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Powell Industries Stock Soars 161% in a Year as $13 Million Buy Lifts Stake to 11% of This Portfolio ↗
Via The Motley Fool
News headline image
Valvoline Delivers 11% Revenue Growth Last Quarter as $11 Million Stake Becomes 6% Portfolio Bet ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
Caesars Stock Down 45% as Fund Slashes Stake by 300,000 Shares ↗
Via The Motley Fool
News headline image
Enviri Stock Up 119% in a Year, and One Fund Decided to Exit Its $5.5 Million Position ↗
Via The Motley Fool
News headline image
The Billion-Dollar Gamble: Why Alta Fundamental Advisers is Doubling Down on a Battered Chemours
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Calumet Exit: What a $7 Million Sell-Off Signals for a Struggling Energy Stock ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Amid a 13% Stock Slide, a Fund Scales Back Its Lucky Strike Exposure by $9 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
From The Chemours Company
Via Business Wire
News headline image
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
XRP ETFs Ignite Market with Near-$1 Billion Debut, Signaling Robust Institutional Appetite
Via BreakingCrypto
Topics ETFs Economy Regulatory Compliance
News headline image
Fund Adds $7.2 Million Powell Stake as the Electrical Supplier Posts Record $181 Million Profit ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
This Fund Just Took a $5.5 Million Stake in a Turnaround Stock Up 143% This Past Year ↗
Via The Motley Fool
News headline image
Top 3 Materials Stocks That Are Preparing To Pump In Q4 ↗
Via Benzinga
News headline image
Chemours (NYSE:CC) Q3 2025 Earnings Miss Estimates, Stock Falls on Weak Guidance ↗
Via Chartmill
Topics Earnings

Frequently Asked Questions

Is Chemours Company (The) Common Stock publicly traded?
Yes, Chemours Company (The) Common Stock is publicly traded.
What exchange does Chemours Company (The) Common Stock trade on?
Chemours Company (The) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Chemours Company (The) Common Stock?
The ticker symbol for Chemours Company (The) Common Stock is CC on the New York Stock Exchange
What is the current price of Chemours Company (The) Common Stock?
The current price of Chemours Company (The) Common Stock is 21.55
When was Chemours Company (The) Common Stock last traded?
The last trade of Chemours Company (The) Common Stock was at 04/02/26 07:00 PM ET
What is the market capitalization of Chemours Company (The) Common Stock?
The market capitalization of Chemours Company (The) Common Stock is 3.19B
How many shares of Chemours Company (The) Common Stock are outstanding?
Chemours Company (The) Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story